Cutera’s truFlex Gains FDA Clearance for Therapeutic Applications
The FDA has expanded indications for Cutera’s truFlex device to include rehabilitative and therapeutic uses beyond aesthetic treatments.
The FDA has expanded indications for Cutera’s truFlex device to include rehabilitative and therapeutic uses beyond aesthetic treatments.
Researchers evaluated a proprietary dual hyaluronic acid complex designed to promote tissue remodeling through biomaterial-based regenerative biostimulation rather than localized inflammation.